DK0973505T3 - Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand - Google Patents

Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand

Info

Publication number
DK0973505T3
DK0973505T3 DK98909460T DK98909460T DK0973505T3 DK 0973505 T3 DK0973505 T3 DK 0973505T3 DK 98909460 T DK98909460 T DK 98909460T DK 98909460 T DK98909460 T DK 98909460T DK 0973505 T3 DK0973505 T3 DK 0973505T3
Authority
DK
Denmark
Prior art keywords
water
pharmaceutical composition
active ingredient
aqueous pharmaceutical
heavily soluble
Prior art date
Application number
DK98909460T
Other languages
Danish (da)
English (en)
Inventor
Giovanni Cavallo
Leonardo Marchitto
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of DK0973505T3 publication Critical patent/DK0973505T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98909460T 1997-02-20 1998-02-12 Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand DK0973505T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000363A IT1289939B1 (it) 1997-02-20 1997-02-20 Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
PCT/EP1998/000816 WO1998036735A1 (fr) 1997-02-20 1998-02-12 Composition pharmaceutique aqueuse comprenant un principe actif essentiellement insoluble dans l'eau

Publications (1)

Publication Number Publication Date
DK0973505T3 true DK0973505T3 (da) 2004-05-03

Family

ID=11376099

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98909460T DK0973505T3 (da) 1997-02-20 1998-02-12 Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand

Country Status (26)

Country Link
US (1) US6337087B1 (fr)
EP (1) EP0973505B1 (fr)
JP (1) JP4299369B2 (fr)
KR (1) KR100515249B1 (fr)
CN (1) CN1135969C (fr)
AR (1) AR011682A1 (fr)
AT (1) ATE257374T1 (fr)
AU (1) AU740619B2 (fr)
BG (1) BG64367B1 (fr)
CA (1) CA2285985C (fr)
CZ (1) CZ296700B6 (fr)
DE (1) DE69821001T2 (fr)
DK (1) DK0973505T3 (fr)
EA (1) EA002281B1 (fr)
ES (1) ES2213894T3 (fr)
GE (1) GEP20022751B (fr)
HU (1) HU225594B1 (fr)
IL (2) IL131354A0 (fr)
IT (1) IT1289939B1 (fr)
PL (1) PL190987B1 (fr)
PT (1) PT973505E (fr)
SK (1) SK282905B6 (fr)
TR (1) TR199901987T2 (fr)
UA (1) UA63939C2 (fr)
WO (1) WO1998036735A1 (fr)
ZA (1) ZA981354B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
US6075045A (en) * 1999-04-28 2000-06-13 Ajinomoto Co., Inc. Method of treating paralysis of the extremities caused by cerebral infarction
JP4894119B2 (ja) * 2001-09-26 2012-03-14 日油株式会社 脂肪酸含有リポソーム分散液
US20040115226A1 (en) * 2002-12-12 2004-06-17 Wenji Li Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
JP2006516571A (ja) * 2003-01-17 2006-07-06 スレッシュオールド ファーマシューティカルズ， インコーポレイテッド 良性前立腺増殖症の処置
US20050238675A1 (en) * 2004-04-26 2005-10-27 Wenjie Li Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CN117695226A (zh) * 2018-12-11 2024-03-15 迪斯拉普申实验室公司 用于递送治疗剂的组合物及其使用方法和制备方法
CN111759807B (zh) * 2019-04-01 2021-06-01 上海谷森医药有限公司 一种环孢素脂质体及其制备方法
WO2020261158A1 (fr) 2019-06-25 2020-12-30 Translatum Medicus Inc. Procédés de fabrication d'acide 2-((1-benzyl-1h-indazol-3-yl)méthoxy)-2-méthylpropanoïque et de ses dérivés

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1264668A (fr) * 1984-06-20 1990-01-23 Pieter R. Cullis Techniques d'extrusion pour la production de liposomes
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
AT396755B (de) * 1992-07-09 1993-11-25 Oesko Gmbh Verfahren zum reinigen eines rauchgasstromes mit hilfe einer waschflüssigkeit
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
AU6047996A (en) * 1995-06-07 1996-12-30 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications

Also Published As

Publication number Publication date
EA002281B1 (ru) 2002-02-28
AR011682A1 (es) 2000-08-30
CN1135969C (zh) 2004-01-28
SK282905B6 (sk) 2003-01-09
DE69821001D1 (de) 2004-02-12
PL190987B1 (pl) 2006-02-28
PT973505E (pt) 2004-05-31
IL131354A (en) 2010-06-30
DE69821001T2 (de) 2004-11-11
ZA981354B (en) 1998-08-17
ATE257374T1 (de) 2004-01-15
PL335208A1 (en) 2000-04-10
EA199900750A1 (ru) 2000-04-24
HUP0000910A2 (hu) 2000-10-28
HU225594B1 (en) 2007-05-02
CZ292699A3 (cs) 2000-01-12
UA63939C2 (uk) 2004-02-16
JP2001519775A (ja) 2001-10-23
BG103739A (en) 2000-06-30
KR100515249B1 (ko) 2005-09-16
CA2285985C (fr) 2008-01-29
IL131354A0 (en) 2001-01-28
HUP0000910A3 (en) 2000-11-28
BG64367B1 (bg) 2004-12-30
EP0973505A1 (fr) 2000-01-26
EP0973505B1 (fr) 2004-01-07
KR20000075480A (ko) 2000-12-15
JP4299369B2 (ja) 2009-07-22
ES2213894T3 (es) 2004-09-01
ITMI970363A1 (it) 1998-08-20
TR199901987T2 (xx) 1999-11-22
SK111199A3 (en) 2000-06-12
AU740619B2 (en) 2001-11-08
US6337087B1 (en) 2002-01-08
AU6398798A (en) 1998-09-09
WO1998036735A1 (fr) 1998-08-27
GEP20022751B (en) 2002-08-26
CZ296700B6 (cs) 2006-05-17
CN1255057A (zh) 2000-05-31
IT1289939B1 (it) 1998-10-19
CA2285985A1 (fr) 1998-08-27

Similar Documents

Publication Publication Date Title
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
DE69942921D1 (de) Osmotische Dosierungsform mit verlängerter Wirkstoffabgabe
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
DK0769965T3 (da) Vandige risperidonformuleringer
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
NO20034149D0 (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
ZA200000603B (en) Use of stilbene derivatives substituted in position 3, as deodrorant active agents in cosmetic compositions.
BR9704554B1 (pt) utilizaÇço de lipÍdios complexos como adiÇÕes de estabilizaÇço para composiÇÕes farmacÊuticas de misturas de enzimas de digestço, composiÇÕes farmacÊuticas soléveis em Água e kit para preparaÇço de soluÇÕes aquosas.
ATE316782T1 (de) Neue orale formulierungen für 5-ht4 agonisten oder antagonisten
PT1056343E (pt) Formulacoes aquosas de parasiticidas para aplicacao dermica
NO981522D0 (no) Aminosyrederivater, deres fremstilling og anvendelse som endotelinantagonister
DK0973505T3 (da) Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
DE60001266D1 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
DK1227817T3 (da) Ciclesonid-holdigt vandigt farmaceutisk præparat
NO985023L (no) Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO985807L (no) Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
NO20025028L (no) 9-oksa-epotilonderivater, fremgangsmÕte for fremstilling derav samt deres anvendelse i farmasöytiske preparater
DE50005076D1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung
DK1086695T3 (da) Antivirale præparater omfattende yohimbin som aktivt princip
NO20032035D0 (no) Terapeutiske midler for heratokonjunktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens
SI0973505T1 (en) Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
NO20002231D0 (no) Fysiologisk akseptable vandige løsninger